AI Article Synopsis
- The study aimed to assess the effectiveness of minimally invasive esophagectomy (MIE) for treating stage II/III esophageal cancer compared to traditional open esophagectomy (OE).
- Researchers compared surgical outcomes between 57 patients undergoing MIE and 57 patients undergoing OE using a propensity scoring system for accuracy.
- Results showed that while the risk of major complications was similar for both methods, MIE significantly improved 5-year overall survival rates compared to OE, suggesting it is a safe and effective option for these cancer stages.
Article Abstract
Background/aim: The purpose of this study was to evaluate the usefulness of minimally invasive esophagectomy (MIE) for stage II/III esophageal cancer (EC).
Patients And Methods: We compared surgical outcomes between MIE and open esohagectomy in EC patients with pStage II/III using the propensity scoring system.
Results: Fifty-seven patients were classified into the MIE group and 57 patients into the open esophagectomy (OE) group. The incidence of major complications was similar between the two groups. The 5-year OS was significantly better in the MIE group (69.0% vs. 35.5%; p=0.004) and no significant difference was observed in the 5-year recurrence-free survival (RFS, 52.2% vs. 29.2%; p=0.064). Multivariate analysis showed MIE was a prognostic factor of OS (p<0.001) and RFS (p=0.032).
Conclusion: MIE was as safe and feasible as OE, and an independent prognostic factor for OS and RFS in patients with stage II/III EC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.21873/anticanres.14106 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!